Article
Advantages of routine next-generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic.
European journal of neurology - 1 Aug 2023
Scaber Jakub, Thompson Alexander G, Farrimond Lucy, Feneberg Emily, Proudfoot Malcolm, Ossher Lynn, Turner Martin R, Talbot Kevin
Abstract excerpt
BACKGROUND: Next-generation sequencing has enhanced our understanding of amyotrophic lateral sclerosis (ALS) and its genetic epidemiology. Outside the research setting, testing is often restricted to those who report a family history. The aim of this study was to explore the added benefit of offering routine genetic testing to all patients in a regional ALS centre. METHODS: C9ORF72 expansion testing and exome...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
